Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients

Drug and Alcohol Dependence

Volumn 105, Issue 1-2, 2009, Pages 33-41

  Baltieri, Danilo Antonio ^a,b,c   Daró, Fabio Ruiz ^a   Ribeiro, Philip Leite ^a   Andrade, Arthur Guerra de ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FACULDADE DE MEDICINA DO ABC   (Brazil)

^c Penitentiary Counseling of São Paulo State ^*  (Brazil)

Author keywords

Alcoholism; Pharmacotherapy; Tobacco; Treatment

Indexed keywords

ALCOHOL; NALTREXONE; PLACEBO; TOPIRAMATE;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; BRAZIL; CIGARETTE SMOKING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG RESPONSE; EVENING DOSAGE; FOLLOW UP; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK REDUCTION; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; OUTPATIENTS; PATIENT COMPLIANCE; RECURRENCE; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 69949097349     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.05.025     Document Type: Article

References (59)

1. Anthenelli R.M., Blom T.J., McElroy S.L., and Keck Jr. P.E. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation. Addiction 103 (2008) 687-694
2. Anton R.F., Moak D.H., and Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin. Exp. Res. 19 (1995) 92-99
3. Baltieri D.A., Daro F.R., Ribeiro P.L., and de Andrade A.G. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103 (2008) 2035-2044
4. Berggren U., Berglund K., Fahlke C., Aronsson E., Eriksson M., and Balldin J. Tobacco use is associated with more severe alcohol dependence, as assessed by the number of DSM-IV criteria, in Swedish male type 1 alcoholics. Alcohol Alcohol. 42 (2007) 247-251
5. Bien T.H., and Burge R. Smoking and drinking: a review of the literature. Int. J. Addict. 25 (1990) 1429-1454
6. Blomqvist O., Hernandez-Avila C.A., Van Kirk J., Rose J.E., and Kranzler H.R. Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol. Alcohol Clin. Exp. Res. 26 (2002) 326-331
7. Brasil Ministério da Saúde. Secretaria de Atenção à Saúde, 2004. Instituto Nacional do Câncer. Coordenação de Prevenção e Vigilância. Por um Mundo sem Tabaco: Mobilização da Sociedade Civil. INCA, Rio de Janeiro, RJ.
8. Burling T.A., Ramsey T.G., Seidner A.L., and Kondo C.S. Issues related to smoking cessation among substance abusers. J. Subst. Abuse 9 (1997) 27-40
9. Byars J.A., Frost-Pineda K., Jacobs W.S., and Gold M.S. Naltrexone augments the effects of nicotine replacement therapy in female smokers. J. Addict. Dis. 24 (2005) 49-60
10. Campayo J.G., Sobradiel N., Alda M., Mas A., Andres E., Magallon R., Crucelaegui A., and Sanz B. Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial. BMC Fam. Pract. 9 (2008) 28
11. Carlini E.A., Galduroz J.C.F., and Notto S.A. Household Survey on Drug Abuse in Brazil: Study Involving the 107 Major Cities of the Country (2001), CEBRID/UNIFESP, São Paulo, Brazil
12. Castro L.A., and Baltieri D.A. The pharmacologic treatment of the alcohol dependence. Rev. Bras. Psiquiatr. 26 (2004) S43-S46
13. Cooney J.L., Cooney N.L., Pilkey D.T., Kranzler H.R., and Oncken C.A. Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction 98 (2003) 913-921
14. Covey L.S., Glassman A.H., and Stetner F. Naltrexone effects on short-term and long-term smoking cessation. J. Addict. Dis. 18 (1999) 31-40
15. Daeppen J.B., Smith T.L., Danko G.P., Gordon L., Landi N.A., Nurnberger Jr. J.I., Bucholz K.K., Raimo E., Schuckit M.A., and The Collaborative Study Group on the Genetics of Alcoholism. Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. Alcohol Alcohol. 35 (2000) 171-175
16. Ellingstad T.P., Sobell L.C., Sobell M.B., Cleland P.A., and Agrawal S. Alcohol abusers who want to quit smoking: implications for clinical treatment. Drug Alcohol Depend. 54 (1999) 259-265
17. Epperson C.N., O'Malley S., Czarkowski K.A., Gueorguieva R., Jatlow P., Sanacora G., Rothman D.L., Krystal J.H., and Mason G.F. Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol. Psychiatry 57 (2005) 44-48
18. Epstein A.M., and King A.C. Naltrexone attenuates acute cigarette smoking behavior. Pharmacol. Biochem. Behav. 77 1 (2004) 29-37
19. Florez G., Garcia-Portilla P., Alvarez S., Saiz P.A., Nogueiras L., and Bobes J. Using topiramate or naltrexone for the treatment of alcohol-dependent patients. Alcohol Clin. Exp. Res. 32 (2008) 1251-1259
20. Friend K.B., and Pagano M.E. Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders. J. Addict. Dis. 24 (2005) 61-75
21. Friend K.B., and Pagano M.E. Timevarying predictors of smoking cessation among individuals in treatment for alcohol abuse and dependence: findings from Project MATCH. Alcohol Alcohol. 42 (2007) 234-240
22. Gulliver S.B., Kalman D., Rohsenow D.J., Colby S.M., Eaton C.A., and Monti P.M. Smoking and drinking among alcoholics in treatment: cross-sectional and longitudinal relationships. J. Stud. Alcohol 61 (2000) 157-163
23. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
24. Hertling I., Ramskogler K., Dvorak A., Klingler A., Saletu-Zyhlarz G., Schoberberger R., Walter H., Kunze M., and Lesch O.M. Craving and other characteristics of the comorbidity of alcohol and nicotine dependence. Eur. Psychiatry 20 (2005) 442-450
25. Hutchison K.E., Monti P.M., Rohsenow D.J., Swift R.M., Colby S.M., Gnys M., Niaura R.S., and Sirota A.D. Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results. Psychopharmacology (Berlin) 142 (1999) 139-143
26. Johnson B.A., Ait-Daoud N., Bowden C.L., DiClemente C.C., Roache J.D., Lawson K., Javors M.A., and Ma J.Z. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361 (2003) 1677-1685
27. Johnson B.A. Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?. Addict. Behav. 29 (2004) 1465-1479
28. Johnson B.A., Ait-Daoud N., Akhtar F.Z., and Javors M.A. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial. Arch. Intern. Med. 165 (2005) 1600-1605
29. Johnson B.A., Rosenthal N., Capece J.A., Wiegand F., Mao L., Beyers K., McKay A., Ait-Daoud N., Anton R.F., Ciraulo D.A., Kranzler H.R., Mann K., O'Malley S.S., and Swift R.M. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298 (2007) 1641-1651
30. Joseph A.M., Willenbring M.L., Nugent S.M., and Nelson D.B. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J. Stud. Alcohol 65 (2004) 681-691
31. Khazaal Y., Cornuz J., Bilancioni R., and Zullino D.F. Topiramate for smoking cessation. Psychiatry Clin. Neurosci. 60 (2006) 384-388
32. King A., de Wit H., Riley R.C., Cao D., Niaura R., and Hatsukami D. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob. Res. 8 (2006) 671-682
33. Lemon S.C., Friedmann P.D., and Stein M.D. The impact of smoking cessation on drug abuse treatment outcome. Addict. Behav. 28 (2003) 1323-1331
34. Li X.C., Karadsheh M.S., Jenkins P.M., and Stitzel J.A. Genetic correlation between the free-choice oral consumption of nicotine and alcohol in C57BL/6JxC3H/HeJ F2 intercross mice. Behav. Brain Res. 157 (2005) 79-90
35. Littleton J., Barron S., Prendergast M., and Nixon S.J. Smoking kills (alcoholics)! shouldn't we do something about it?. Alcohol Alcohol. 42 (2007) 167-173
36. Ma J.Z., Ait-Daoud N., and Johnson B.A. Topiramate reduces the harm of excessive drinking: implications for public health and primary care. Addiction 101 (2006) 1561-1568
37. Marks J.L., Hill E.M., Pomerleau C.S., Mudd S.A., and Blow F.C. Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. J. Subst. Abuse Treat. 14 (1997) 521-527
38. Martin J.E., Calfas K.J., Patten C.A., Polarek M., Hofstetter C.R., Noto J., and Beach D. Prospective evaluation of three smoking interventions in 205 recovering alcoholics: one-year results of Project SCRAP-Tobacco. J. Consult. Clin. Psychol. 65 (1997) 190-194
39. Martin R.A., Rohsenow D.J., MacKinnon S.V., Abrams D.B., and Monti P.M. Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend. 83 (2006) 73-78
40. Meyerhoff D.J., Tizabi Y., Staley J.K., Durazzo T.C., Glass J.M., and Nixon S.J. Smoking comorbidity in alcoholism: neurobiological and neurocognitive consequences. Alcohol Clin. Exp. Res. 30 (2006) 253-264
41. Nixon S.J., Lawton-Craddock A., Tivis R., and Ceballos N. Nicotine's effects on attentional efficiency in alcoholics. Alcohol Clin. Exp. Res. 31 (2007) 2083-2091
42. O'Malley S.S., Cooney J.L., Krishnan-Sarin S., Dubin J.A., McKee S.A., Cooney N.L., Blakeslee A., Meandzija B., Romano-Dahlgard D., Wu R., Makuch R., and Jatlow P. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med. 166 (2006) 667-674
43. Palfai T.P., Monti P.M., Ostafin B., and Hutchison K. Effects of nicotine deprivation on alcohol-related information processing and drinking behavior. J. Abnorm. Psychol. 109 (2000) 96-105
44. Perkins K.A. Smoking cessation in women, special considerations. CNS Drugs 15 (2001) 391-411
45. Prendergast M.A., Rogers D.T., Barron S., Bardo M.T., and Littleton J.M. Ethanol and nicotine: a pharmacologic balancing act?. Alcohol Clin. Exp. Res. 26 (2002) 1917-1918
46. Prochaska J.J., Delucchi K., and Hall S.M. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J. Consult. Clin. Psychol. 72 (2004) 1144-1156
47. Raistrick D., Dunbar G., and Davidson R. Development of a questionnaire to measure alcohol dependence. Br. J. Addict. 78 (1983) 89-95
48. Ray L.A., Miranda Jr. R., Kahler C.W., Leventhal A.M., Monti P.M., Swift R., and Hutchison K.E. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology (Berlin) 193 (2007) 449-456
49. Rohsenow D.J., Monti P.M., Colby S.M., Gulliver S.B., Swift R.M., and Abrams D.B. Naltrexone treatment for alcoholics: effect on cigarette smoking rates. Nicotine Tob. Res. 5 (2003) 231-236
50. Rohsenow D.J., Monti P.M., Hutchison K.E., Swift R.M., MacKinnon S.V., Sirota A.D., and Kaplan G.B. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp. Clin. Psychopharmacol. 15 (2007) 81-92
51. Romberger D.J., and Grant K. Alcohol consumption and smoking status: the role of smoking cessation. Biomed. Pharmacother. 58 (2004) 77-83
52. Schmidt L.G., and Smolka M. Relapse prevention in alcoholics by cigarette smoking? Involvement of nicotinic-dopaminergic mechanisms. Alcohol 24 (2001) 111-115
53. Sobell L.C., Brown J., Leo G.I., and Sobell M.B. The reliability of the alcohol timeline followback when administered by telephone and by computer. Drug Alcohol Depend. 42 (1996) 49-54
54. Sobell L.C., Sobell M.B., and Agrawal S. Self-change and dual recoveries among individuals with alcohol and tobacco problems: current knowledge and future directions. Alcohol Clin. Exp. Res. 26 (2002) 1936-1938
55. Stotts A.L., Schmitz J.M., and Grabowski J. Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both?. Drug Alcohol Depend. 69 (2003) 1-7
56. Sullivan M.A., and Covey L.S. Current perspectives on smoking cessation among substance abusers. Curr. Psychiatry Rep. 4 (2002) 388-396
57. Sutherland G., Stapleton J.A., Russell M.A., and Feyerabend C. Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology (Berlin) 120 (1995) 418-425
58. Walsh Z., Epstein A., Munisamy G., and King A. The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. J. Addict. Dis. 27 (2008) 65-72
59. World Bank. Curbing the epidemic: governments and the economics of tobacco control. Tob. Control 8 (1999) 196-201